Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. (SYRS) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 219 transactions totaling $60.9M, demonstrating a bullish sentiment with $43.4M in net insider flow. The most recent transaction on Sep 16, 2024 involved a transaction of 2,667 shares valued at $0.
SYRS Insider Activity Summary
Who Is Buying SYRS Stock?
No significant insider buying has been recorded for SYRS in the recent period.
Who Is Selling SYRS Stock?
No significant insider selling has been recorded for SYRS in the recent period.
Is Syros Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SYRS is bullish with an Insider Alignment Score of 86/100 and a net flow of $43.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SYRS Frequently Asked Questions
Understanding SYRS Insider Activity
Insider trading at Syros Pharmaceuticals, Inc. (SYRS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading SYRS stock, having executed 219 transactions in the past 90 days. The most active insider is Srinivas Akkaraju (Executive), who has made 17 transactions totaling $14.8M.
Related Tools
Track Syros Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at SYRS file new Form 4 transactions